HomeNLSP • NASDAQ
add
NLS Pharmaceutics AG
Previous close
$1.60
Day range
$1.55 - $1.79
Year range
$1.30 - $18.39
Market cap
3.38M USD
Avg Volume
74.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 791.39K | -62.82% |
Net income | 27.51K | 101.21% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -790.56K | 62.81% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.67M | 85.52% |
Total assets | 2.23M | 20.93% |
Total liabilities | 826.76K | -92.26% |
Total equity | 1.41M | — |
Shares outstanding | 3.16M | — |
Price to book | -3.81 | — |
Return on assets | -88.60% | — |
Return on capital | -140.68% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 27.51K | 101.21% |
Cash from operations | -1.37M | -14.63% |
Cash from investing | -1.96K | — |
Cash from financing | 1.93M | 135.90% |
Net change in cash | 556.32K | 247.61% |
Free cash flow | -546.75K | 58.60% |
About
Founded
2015
Website
Employees
3
